These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 7075489)

  • 1. [Thromboembolism prevention in surgical medicine: heparin or heparin-dihydroergotamine?].
    Rasche H; Vollmar J; Burri C; Beger HG; Kilian J; Kinzl J; Krautzberger W; Wenzke C
    Langenbecks Arch Chir; 1983; 360(2):81-95. PubMed ID: 6355715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications in drug prevention of thromboembolism].
    Tittel K
    Unfallchirurgie; 1985 Jun; 11(3):150-5. PubMed ID: 4035815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ergotism--an important complication of drug thromboembolism prevention].
    Krupp P; Meyer HE
    Dtsch Med Wochenschr; 1982 Jan; 107(1):36. PubMed ID: 7056149
    [No Abstract]   [Full Text] [Related]  

  • 4. [Guides to ergotism, a too little recognized complication of trauma].
    Voigt J; Dortenmann J
    Aktuelle Traumatol; 1983 Feb; 13(1):46-9. PubMed ID: 6132532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ergotism within the scope of the postoperative prevention of thromboembolism].
    Kneist W; Heesen U; Assmann H
    Zentralbl Chir; 1987; 112(22):1426-35. PubMed ID: 3439378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ergotism--a serious complication in the chemical prevention of thromboembolism with heparin-DHE].
    van den Berg E; Walterbusch G; Gotzen L; Rumpf KD; Otten B; Fröhlich H
    Vasa; 1983; 12(1):64-7. PubMed ID: 6837130
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and therapy of ergotism following the use of heparin-DHE in thrombosis prevention].
    Wiesmann W; Peters PE; Irskens U; Schwering H
    Rofo; 1987 Oct; 147(4):446-9. PubMed ID: 2825270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ergotism--a severe complication of drug prevention of thromboembolism].
    van den Berg E; Walterbusch G
    Dtsch Med Wochenschr; 1982 May; 107(18):716-8. PubMed ID: 7075489
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complications following preventive treatment of thromboembolism with Dihydergot-heparin].
    Andersen KH; Jeppesen IS
    Ugeskr Laeger; 1989 Aug; 151(33):2072-5. PubMed ID: 2672498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
    Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is known about the action of dihydroergotamine on the vasculature in man?
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):677-82. PubMed ID: 6396240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylaxis of venous thrombosis, yes but...].
    Korin JD; Sánchez Avalos JC
    Medicina (B Aires); 1996; 56(3):299-307. PubMed ID: 9035489
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.